Artificial intelligence approach fighting COVID-19 with repurposing drugs.

Journal: Biomedical journal
Published Date:

Abstract

BACKGROUND: The ongoing COVID-19 pandemic has caused more than 193,825 deaths during the past few months. A quick-to-be-identified cure for the disease will be a therapeutic medicine that has prior use experiences in patients in order to resolve the current pandemic situation before it could become worsening. Artificial intelligence (AI) technology is hereby applied to identify the marketed drugs with potential for treating COVID-19.

Authors

  • Yi-Yu Ke
    Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Taiwan. Electronic address: yiyuke@nhri.edu.tw.
  • Tzu-Ting Peng
    Animal Technology Laboratories, Agricultural Technology Research Institute, Hsinchu, Taiwan.
  • Teng-Kuang Yeh
    Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Taiwan.
  • Wen-Zheng Huang
    Animal Technology Laboratories, Agricultural Technology Research Institute, Hsinchu, Taiwan.
  • Shao-En Chang
    Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Taiwan.
  • Szu-Huei Wu
    Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Taiwan.
  • Hui-Chen Hung
    Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Taiwan.
  • Tsu-An Hsu
    Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Taiwan.
  • Shiow-Ju Lee
    Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Taiwan.
  • Jeng-Shin Song
    Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Taiwan.
  • Wen-Hsing Lin
    Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Taiwan.
  • Tung-Jung Chiang
    Office of Environment, Safety, and Health, National Health Research Institutes, Miaoli, Taiwan.
  • Jiunn-Horng Lin
    Animal Technology Laboratories, Agricultural Technology Research Institute, Hsinchu, Taiwan.
  • Huey-Kang Sytwu
    National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.
  • Chiung-Tong Chen
    Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Taiwan. Electronic address: ctchen@nhri.edu.tw.